Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

BACKGROUND: Thioguanine (TG) is a thiopurine which has been used for patients with inflammatory bowel disease (IBD), who have failed azathioprine (AZA) or mercaptopurine (MP) due to adverse events or suboptimal response. Its widespread use has been hampered due to concerns about nodular regenerative...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Gastroenterol
Hlavní autoři: Bayoumy, Ahmed B., van Liere, Elsa L. S. A., Simsek, Melek, Warner, Ben, Loganayagam, Aathavan, Sanderson, Jeremy D., Anderson, Simon, Nolan, Jonathan, de Boer, Nanne K., Mulder, Chris J. J., Ansari, Azhar
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488521/
https://ncbi.nlm.nih.gov/pubmed/32917155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01441-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky